Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...
Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to be high, but these may vary. Leukemia is a type of cancer involving human blood ...
Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic ...
A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events among those treated with zanubrutinib compared with ibrutinib.
Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says.The antibi ...
To investigate the link between unconventional oil and natural gas development and childhood ALL, researchers conducted a case-control study of children in Colorado.
Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., ...
Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for CLL and ...
Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what ...
For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...
Small lymphocytic lymphoma (SLL) is a slow-growing cancer of the immune system. It is typically manageable with treatment, but outlook can depend on a few factors. SLL is one type of non-Hodgkin ...